NT-proBNP correlates with LVEF decline in HER2-positive breast cancer patients treated with trastuzumab.
Cardiooncology
; 5: 4, 2019.
Article
in En
| MEDLINE
| ID: mdl-32154011
Full text:
1
Collection:
01-internacional
Health context:
1_ASSA2030
/
2_ODS3
Database:
MEDLINE
Type of study:
Observational_studies
/
Risk_factors_studies
Language:
En
Journal:
Cardiooncology
Year:
2019
Document type:
Article